Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy

Chronic heart failure (HF) is a major cause of morbidity and mortality particularly in the elderly and a growing healthcare burden in Italy. The objective was to assess the cost-effectiveness of candesartan cilexetil, an angiotensin II type 1 receptor blocker (ARB) for the treatment of HF. A pre-spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombo, Giorgio L, Caruggi, Mauro, Ottolini, Chiara, Maggioni, Aldo P
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464765/
https://www.ncbi.nlm.nih.gov/pubmed/18629370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464765/
https://www.ncbi.nlm.nih.gov/pubmed/18629370

Ejemplares similares